Description
CJC-1295 without DAC
CJC-1295 without DAC is a synthetic peptide classified under the growth hormone-releasing hormone (GHRH) group. It functions by stimulating the pituitary gland to release growth hormone (GH) and insulin-like growth factor 1 (IGF-1) into the bloodstream. Unlike its DAC variant, CJC-1295 without DAC has a shorter half-life, requiring more frequent dosing for sustained GH elevation. This peptide is commonly utilized in research and clinical studies to explore its potential in treating growth hormone deficiency, enhancing muscle mass, bone density, and overall metabolic function. However, its administration should be supervised by medical professionals due to potential side effects and regulatory considerations.